Shihchen Kuo

University of Michigan–Ann Arbor

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

Kimberly Drews

Professor

Pennington Biomedical Research Center

UNITED STATES

View details

Caroline Presley

Assistant Professor

The University of Alabama

UNITED STATES

View details

Anne Bantle

Faculty, Assistant Professor

University of Minnesota

UNITED STATES

View details

Claire Hoogendoorn

Research Assistant Professor

Yeshiva University

UNITED STATES

View details

Andrea L Cherrington

The University of Alabama

UNITED STATES

View details

Aanand Naik

The University of Texas Health Science Center at Houston

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shihchen Kuo

Research Interests

Explore related searches

Contact this professor

Articles (10)

Analysis of Long-term Follow-up of a Randomized Clinical Trial With Departures From Assigned Treatments: Estimation of Metformin Effects on Diabetes and Its Complications in the Diabetes Prevention Program Outcomes Study

Is Screening for Heart Failure and Peripheral Artery Disease Warranted in Asymptomatic Adults With Diabetes? A Perspective on the 2025 American Diabetes Association “Standards of Care in Diabetes”

Economic burdens of type 1 diabetes and its complications: A nationwide, longitudinal analysis

Cost-effectiveness of the National Diabetes Prevention Program: A Real-world, 2-Year Prospective Study

Differential Effects of Type 2 Diabetes Treatment Regimens on Diabetes Distress and Depressive Symptoms in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

Impact of Glucose-Lowering Medications on Health-Related Quality of Life in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

Lower risks of cirrhosis and hepatocellular carcinoma with GLP-1RAs in type 2 diabetes: A nationwide cohort study using target trial emulation framework.

Chronic kidney outcomes associated with GLP-1 receptor agonists versus long-acting insulins among type 2 diabetes patients requiring intensive glycemic control: a nationwide cohort study.

Diabetes Care Barriers, Use, and Health Outcomes in Younger Adults With Type 1 and Type 2 Diabetes.

Value of GLP-1 receptor agonists versus long-acting insulins for type 2 diabetes patients with and without established cardiovascular or chronic kidney diseases: A model-based cost-effectiveness analysis using real-world data

Collaborators (6)

Kimberly Drews

Caroline Presley

Anne Bantle

Claire Hoogendoorn

Andrea L Cherrington

Aanand Naik

Make your next move.